Triheptanoin

Triheptanoin, sold under the brand name Dojolvi, is a medication for the treatment of children and adults with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD).[1][2][3] The most common adverse reactions include abdominal pain, diarrhea, vomiting, and nausea.[1][2][3] Triheptanoin was approved for medical use in the United States in June 2020.[4][2&a... [wikipedia]